Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lale Kostakoglu

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
European Journal of Radiology|October 14, 2014
State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settingsCharles Mesguich, Reza Fardanesh, Lawrence Tanenbaum, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 19, 2011
Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment settingKevin G King, Arpakorn Kositwattanarerk, Eric Genden, et al.
Cancer|March 29, 2002
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphomaLale Kostakoglu, John P Leonard, Ichiei Kuji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's diseaseLale Kostakoglu, Morton Coleman, John P Leonard, et al.
Abdominal Imaging|April 6, 2011
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)Katherine Cameron, Sivan Golan, William Simpson, et al.
Medical Physics|August 5, 2016
Optimization of yttrium-90 PET for simultaneous PET/MR imaging: A phantom studyMootaz Eldib, Niels Oesingmann, David D Faul, et al.
Clinical Nuclear Medicine|March 19, 2015
Direct comparison of neck pinhole dual-tracer and dual-phase MIBI accuracies with and without SPECT/CT for parathyroid adenoma detection and localizationSherif I Heiba, Manli Jiang, Javier Rivera, et al.
European Journal of Haematology|January 5, 2011
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myelomaBrian M Elliott, Steven Peti, Keren Osman, et al.
Seminars in Oncology|October 23, 2003
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigenNeil H Bander, David M Nanus, Matthew I Milowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2004
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancerMatthew I Milowsky, David M Nanus, Lale Kostakoglu, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
European Journal of Radiology|October 14, 2014
State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settingsCharles Mesguich, Reza Fardanesh, Lawrence Tanenbaum, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|March 19, 2011
Cancers of the oral cavity and oropharynx: FDG PET with contrast-enhanced CT in the posttreatment settingKevin G King, Arpakorn Kositwattanarerk, Eric Genden, et al.
Cancer|March 29, 2002
Comparison of fluorine-18 fluorodeoxyglucose positron emission tomography and Ga-67 scintigraphy in evaluation of lymphomaLale Kostakoglu, John P Leonard, Ichiei Kuji, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2002
PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's diseaseLale Kostakoglu, Morton Coleman, John P Leonard, et al.
Abdominal Imaging|April 6, 2011
Recurrent pancreatic carcinoma and cholangiocarcinoma: 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT)Katherine Cameron, Sivan Golan, William Simpson, et al.
Medical Physics|August 5, 2016
Optimization of yttrium-90 PET for simultaneous PET/MR imaging: A phantom studyMootaz Eldib, Niels Oesingmann, David D Faul, et al.
Clinical Nuclear Medicine|March 19, 2015
Direct comparison of neck pinhole dual-tracer and dual-phase MIBI accuracies with and without SPECT/CT for parathyroid adenoma detection and localizationSherif I Heiba, Manli Jiang, Javier Rivera, et al.
European Journal of Haematology|January 5, 2011
Combining FDG-PET/CT with laboratory data yields superior results for prediction of relapse in multiple myelomaBrian M Elliott, Steven Peti, Keren Osman, et al.
Seminars in Oncology|October 23, 2003
Targeted systemic therapy of prostate cancer with a monoclonal antibody to prostate-specific membrane antigenNeil H Bander, David M Nanus, Matthew I Milowsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2004
Phase I trial of yttrium-90-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for androgen-independent prostate cancerMatthew I Milowsky, David M Nanus, Lale Kostakoglu, et al.
Pageof 12